login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
PROVENTION BIO INC (PRVB) Stock News
USA
- NASDAQ:PRVB -
US74374N1028
-
Common Stock
24.98
USD
+0.75 (+3.1%)
Last: 4/26/2023, 8:02:36 PM
25
USD
+0.02 (+0.08%)
After Hours:
4/26/2023, 8:02:36 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
PRVB Latest News, Press Relases and Analysis
All
Press Releases
2 years ago - By: Benzinga
- Mentions:
SNY
TLSA
Tiziana Life Sciences (NASDAQ: TLSA) Announces Positive Data In Its Secondary-Progressive Multiple Sclerosis Trial, What Could This Mean For The Company?
3 years ago - By: Seeking Alpha
Provention Bio gains after HSR waiting period for Sanofi deal expired (NASDAQ:PRVB)
3 years ago - By: Benzinga
- Mentions:
SGEN
SNY
TLSA
TBPH
...
Tiziana Life Sciences Has Only Fully Human Anti-CD3 mAB In Clinical Studies, Could Be Poised To Improve Care For Patients With Severe Multiple Sclerosis
3 years ago - By: The Motley Fool
- Mentions:
SNY
Is Sanofi Stock a Buy Now?
3 years ago - By: The Motley Fool
- Mentions:
SNY
Why Provention Bio Stock Skyrocketed 256% This Week
3 years ago - By: Kahn Swick & Foti, LLC
PROVENTION BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Provention Bio, Inc. - PRVB
3 years ago - By: Investor's Business Daily
- Mentions:
CS
JPM
BAC
FRC
...
Stock Market Diverges Amid Bank Woes, Growth Gains; First Republic, Credit Suisse, Meta In Focus: Weekly Review
3 years ago - By: InvestorPlace
- Mentions:
FRC
SNCE
Why Is First Republic Bank (FRC) Stock Down 61% Today?
3 years ago - By: InvestorPlace
- Mentions:
SNCE
Why Is Science 37 (SNCE) Stock Up 9% Today?
3 years ago - By: Kahn Swick & Foti, LLC
PROVENTION BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Provention Bio, Inc. - PRVB
3 years ago - By: Ademi LLP
Shareholder Alert: Ademi LLP investigates whether Provention Bio, Inc. has obtained a Fair Price in its transaction with Sanofi
3 years ago - By: InvestorPlace
- Mentions:
SNY
Why Is Provention Bio (PRVB) Stock Up 263% Today?
3 years ago - By: Seeking Alpha
- Mentions:
ZIM
ZYXI
ZEV
PFE
...
Hot Stocks: ZIM, ZYXI rise; PRVB, SGEN jumps on M&A deal; ILMN, up; ZEV, FRC, SCHW slide
3 years ago - By: Investor's Business Daily
- Mentions:
PFE
SGEN
SNY
Pfizer Officially Nabs Seagen For $43 Billion; Provention Soars On Sanofi Deal
3 years ago - By: Halper Sadeh LLC
PRVB STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of Provention Bio, Inc. Is Fair to Shareholders
3 years ago - By: InvestorPlace
- Mentions:
SNY
SNCE
CALT
AGBA
...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Please enable JavaScript to continue using this application.
